Akebia Therapeutics
AKBA
#8131
Rank
S$0.43 B
Marketcap
S$1.63
Share price
-3.08%
Change (1 day)
-66.93%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: S$0.43 Billion

As of July 2026 Akebia Therapeutics has a market cap of S$0.43 Billion. This makes Akebia Therapeutics the world's 8131th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.43 B-22.91%
2025S$0.56 B-2.2%
2024S$0.57 B87.45%
2023S$0.30 B116.81%
2022S$0.14 B-73.38%
2021S$0.53 B-0.16%
2020S$0.53 B-48.36%
2019S$1.03 B17.4%
2018S$0.88 B-6.07%
2017S$0.94 B62.82%
2016S$0.57 B3.04%
2015S$0.56 B78.86%
2014S$0.31 B

End of Day market cap according to different sources

On Jul 22nd, 2026 the market cap of Akebia Therapeutics was reported to be:

S$0.43 Billion
by Nasdaq info icon info icon
S$0.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$793.72 B 181,955.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$375.29 B 85,981.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$254.82 B 58,348.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S$3.02 B 592.90%๐Ÿ‡บ๐Ÿ‡ธ USA